23andMe Has a New Genetic Cancer Test. But the Results Don ’t Tell You the Whole Story
Consumer genetics company 23andMe is diving deeper into the medical space. On Jan. 22, the company announced that the Food and Drug Administration (FDA) approved its newest report, which can flag whether people have genetic variants that may raise their risk of developing colorectal cancer. The new test looks for two gene variants associated with MUTYH-associated polyposis, an inherited colorectal cancer syndrome. “If left unchecked, carrying both of these variants or having two copies of one increases the risk of developing colorectal cancer to between 43 and 100 percent,” according to 23andMe. The test will be available as part of 23andMe’s Health and Ancestry spit test (which costs $199), but as with many of the company’s more sensitive reports, users must opt in to receive their results. “For people who get that two-variant result, this can be absolutely life-saving,” says Jamaica Perry, senior product scientist at 23andMe. “Colorectal cancer is something that can get pretty far along before somebody might notice symptoms of it. If somebody finds out in their 20s or 30s that they have this increased risk, that could actually help them set up a surveillance plan with their doctor and give them a much better life.” But a simple genetic test doesn’t tell the whole story. The vast majority of colorectal cancers aren’t caused by known genetic factors, so a person who doesn’t test positive for these variants may...
CONCLUSIONS In a summary, by inhibiting the STAT3 activation, esculetin shows potential anticancer effects against the laryngeal cancer. PMID: 31630150 [PubMed - in process]
Conclusion Cognitive rehabilitation is able to prolong the independence of the patient in performing activities of daily living and generate functional and structural changes. As a consequence of the finding of few studies that met the eligibility criteria, we also verified the need for more controlled studies and greater application control, considering the high risk of bias in the studies used.
Conclusions Nuclear transcription receptors, cerebral cortex and hippocampus, microglia, and amyloid beta protein have shown significant importance in the pathogenesis of Alzheimer ’ s disease in this study.
His research brought an end to radical mastectomy, and he pioneered the design and implementation of large-scale multi-institutional randomized clinical trials.Medscape Medical News
Authors: Campos-Borges HC, Sanz-González SM, Zanón-Moreno V, Millán Salvador JM, Pinazo-Duran MD PMID: 31629562 [PubMed - as supplied by publisher]
Publication date: December 2019Source: Food Research International, Volume 126Author(s): Dele Raheem, António Raposo, Oluwatoyin Bolanle Oluwole, Maaike Nieuwland, Ariana Saraiva, Conrado CarrascosaAbstractGlobally, there is a need to seek alternative sources of protein in addition to meat. This has led to considerable interest in edible insects. Such insects form part of cultures and diets in many Asian and African countries, and are an excellent source of essential nutrients, minerals, vitamins and proteins. Furthermore, they have been reported to be sustainable. The ecological importance of insects is related to ...
The current clinical study is aimed at evaluating the clinical relevance of an innovative device (called CyPaM2 device) that for the first ...
More News: Alzheimer's | Bladder Cancer | Breast Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | Diabetes | Diets | Eating Disorders & Weight Management | Endocrinology | Endometrial Cancer | Food and Drug Administration (FDA) | Genetics | Health | HNPCC | Jamaica Health | Learning | Lynch Syndrome | Marketing | Nutrition | Obesity | Ovarian Cancer | Ovaries | Parkinson's Disease | Smokers | Sports Medicine | Universities & Medical Training